Nighan Warren JR's Form 4 filing
Angiodynamics Inc (ANGO) · filed Oct 10, 2024
- Accession no.
- 0001140361-24-043263
- Filed
- Oct 10, 2024
- Trade date
- Oct 7-10, 2024
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.29K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nighan Warren JRCIK 0001507345 | Officer (SVP Quality and Regulatory) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2024 | Common Stock | PPurchaseAcquired | +768 | $6.09 | +$4,677.12 | 45,777 | Direct | |
| Oct 10, 2024 | Common Stock | PPurchaseAcquired | +100 | $6.08 | +$608 | 45,877 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.